Navigation Links
CEL-SCI Corporation Releases Letter to Shareholders
Date:9/10/2007

VIENNA, Va., Sept. 10 /PRNewswire-FirstCall/ -- The following letter is being released by CEL-SCI CORPORATION (Amex: CVM) to its shareholders:

Dear Fellow Shareholders:

The past 12 months have been the most successful ever for CEL-SCI Corporation. The U.S. Food and Drug Administration (FDA) granted us the go- ahead for a Phase III (last phase) clinical trial with our cancer drug Multikine(R) and also granted Multikine Orphan drug designation. Following the excellent developments at the Company, we were able to raise $30 million, half in equity and the other half in the form of the acquisition and build out of a manufacturing facility for Multikine which will then be leased to us for 20 years. We feel that we finally have the ability to move forward rapidly since CEL-SCI is now properly financed and all the pieces have fallen into place.

These recent successes follow years of difficulty when we operated with very little capital and the path to the marketing approval for Multikine was not yet clear. We believe that there is a high likelihood of being successful in the upcoming Phase III study because 1) we have designed the study to require a much lower level of improvement in overall survival than the 33% improvement in overall survival we saw in our last Phase II study, and 2) Multikine so far has been shown to be safe, and well tolerated. It is toxic only to cancer cells.

Our goal is to receive world-wide marketing approval for Multikine as a first line standard of care drug for advanced primary head and neck cancer patients. We are not aware of any other biotech company that has ever gone for first line standard of care in cancer as its first indication. Typically drugs are developed and appro
'/>"/>

SOURCE CEL-SCI Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. CEL-SCIS CEL-1000 Shown to Significantly Enhance Immune Response Against Avian Flu Antigen in Animals
2. CEL-SCI Presents Long-Term Cancer Survival Data With Multikine
3. CEL-SCIs Cel-1000 Shown to Significantly Enhance Immune Response Against Hepatitis B Antigen in Animals
4. Alfacell Corporation to Present at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
5. Millipore Corporation Announces New ReNcell Data from Collaboration with ReNeuron
6. NanoBio Corporation Announces Positive Phase 1 Clinical Results for Topical Treatment for Onychomycosis
7. Alba Therapeutics Corporation Reports Preliminary Phase IIa Clinical Trial Results for AT-1001 for the Treatment of Celiac Disease
8. EpiCept Corporation to Present New NP-1 Data at American Pain Society Meeting
9. Insmed Releases Positive Results from Iplex Phase II HIV-Associated Adipose Redistribution Syndrome Clinical Study
10. State of Diabetes in Pittsburgh: Pittsburgh Business Group on Health Releases Report
11. Bipolar Disorder in Children Difficult to Diagnose, Reports the Harvard Mental Health Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... BUFFALO, N.Y. , Dec. 24, 2014 ... been dosed with KX2-361 at Roswell Park Cancer Institute. ... a small molecule drug that has shown potent inhibitory ... lines, including those that are resistant to Temozolomide (T98G), ... malignant glioma. In a well-established brain tumor mouse model, ...
(Date:12/24/2014)... and FARMINGTON, Conn. , ... (NYSE MKT: PTN), a biopharmaceutical company developing targeted, ... with significant unmet medical need and commercial potential, ... private placement of 2,050,000 shares of its common ... shares of its common stock.  Funds under the ...
(Date:12/24/2014)... , Dec. 23, 2014 ResMed (NYSE: ... infringement action against Chinese medical device manufacturer BMC Medical Co., ... today that BMC,s masks listed below infringe ResMed,s patents, and ... these masks in the United States : ... nasal mask , Willow nasal pillows mask , ...
Breaking Medicine Technology:Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 2Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 2Palatin Completes $20 Million Equity and $10 Million Debt Financings 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 4ResMed Wins Patent Infringement Lawsuit Against Chinese Manufacturer BMC Medical 2
... Sysmex America, Inc. (SAI), a leading medical ... announced that Laboratory Corporation of America® Holdings (LabCorp®) ... five-year agreement for Sysmex America, Inc. to provide ... laboratories.  Implementation of the systems has been completed. ...
... 10 Varian Medical Systems (NYSE: ... linear accelerator for fast, powerful and efficient cancer treatments ... exhibition in Barcelona next week. A fully-featured TrueBeam system ... annual ESTRO meeting (Booth No. 320). TrueBeam ...
Cached Medicine Technology:Sysmex America Announces LabCorp Hematology Automation Agreement 2Varian Medical Systems Spotlights TrueBeam Treatment System for First Time in Europe at ESTRO 2010, September 12-16, Barcelona 2Varian Medical Systems Spotlights TrueBeam Treatment System for First Time in Europe at ESTRO 2010, September 12-16, Barcelona 3
(Date:12/24/2014)... December 24, 2014 New studies reveal that ... hearing loss related depression (March 6, 2014, JAMA Otolaryngology*). And ... hearing loss (about 50 percent according to recent polls) facing ... on how a person feels and relates to the world. ... improvements are also made by way of:, , ...
(Date:12/24/2014)... York, New York (PRWEB) December 24, 2014 ... ( http://www.xareltolawsuit2015.com/ ) that allege the blood thinner ... complications has outlined a leadership structure for the ... Order dated December 17th, the Court plans to ... the parties and also plans on appointing a ...
(Date:12/24/2014)... December 25, 2014 Today, Yunx.co.uk, a ... evening dresses and other special occasion outfits, unveils ... models are offered at discounted prices, up to 80% ... young ladies with their fashionable designs, gorgeous looks and ... exception. The business is devoted to designing and offering ...
(Date:12/24/2014)... 2014 Mike Billings , PT, ... Derek Fenwick, PT, MBA, GCS, Director of Professional ... from the passing of the Improving Medicare Post-Acute ... this taping of the Infinicast, the two leaders discuss ... Social Security Act to standardize post-acute assessment data for ...
(Date:12/24/2014)... Dennis Thompson HealthDay Reporter ... bisexual men who have abstained from sex for one year will ... new federal policy that would reverse a 31-year ban on donations ... and Drug Administration announced Tuesday its intention to release a new ... to blood donations from gay men. The FDA is changing ...
Breaking Medicine News(10 mins):Health News:Recent Studys Underscore the Fact That One of the Best Gifts to Give This Holiday Season is a Hearing Test 2Health News:Recent Studys Underscore the Fact That One of the Best Gifts to Give This Holiday Season is a Hearing Test 3Health News:Recent Studys Underscore the Fact That One of the Best Gifts to Give This Holiday Season is a Hearing Test 4Health News:Recent Studys Underscore the Fact That One of the Best Gifts to Give This Holiday Season is a Hearing Test 5Health News:Recent Studys Underscore the Fact That One of the Best Gifts to Give This Holiday Season is a Hearing Test 6Health News:Court Overseeing Federal Xarelto Lawsuits Issues Coordination Order, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal Xarelto Lawsuits Issues Coordination Order, Bernstein Liebhard LLP Reports 3Health News:Yunx.co.uk Unveils 65 New Bridesmaid Dresses for the UK market 2Health News:Latest Episode of Infinicast Features Infinity Rehab President Discussing IMPACT Act of 2014 and Changes for Post-Acute Therapy Providers in 2015 2Health News:FDA to Lift Ban on Blood Donations by Gay Men 2Health News:FDA to Lift Ban on Blood Donations by Gay Men 3
... ... tied to the loss of independence, and at the root of that ... accompany aging. But staying active is worth the effort, according to Home ... underscores the mental and physical value of being fit, Home Instead launched ...
... Lightweight, cordless design ... ... pounds and with a sound level of only 58 dBA, the new Adgility™ XPB ... Powered by a lithium ion battery with 30 minutes of cleaning time, the Adgility XPB ...
... better survival rates a year after intensive care , TUESDAY, ... above the level ordinarily regarded as dangerous -- is a ... intensive care unit because of chest pains that indicate a ... involved 119,151 people admitted to ICUs for chest pain between ...
... RALEIGH, N.C. , March 23 ... non-profit organization dedicated to exposing government corruption and educating ... allegations of public corruption related to the passage or ... into law today.   Citizens nationwide can anonymously and ...
... issued the following statement on the health reform legislation that was signed into law today by President Obama:   , ... , , ... ... ...
... to reduce healthcare costs edited by Stephan Kudyba, an ... be released early this May. Healthcare Informatics: Improving Efficiency ... technologies and information management by healthcare providers to increase ... The text describes evolving areas of ...
Cached Medicine News:Health News:Senior Fear Factors: What Aging Americans Fear Most 2Health News:Senior Fear Factors: What Aging Americans Fear Most 3Health News:Advance Introduces the Adgility™ XPB Battery Backpack Vacuum – the Lightest in the Industry, 2Health News:When Heart Is in Crisis, High Blood Pressure a Good Sign 2Health News:When Heart Is in Crisis, High Blood Pressure a Good Sign 3Health News:Foundation for Ethics in Public Service, Inc. is Available to Review Allegations of Fraud or Corruption Related to The Healthcare Reform Bill 2Health News:Alzheimer's Foundation of America Hails Significant Provisions for Dementia Community in Health Reform Law 2Health News:Alzheimer's Foundation of America Hails Significant Provisions for Dementia Community in Health Reform Law 3Health News:Alzheimer's Foundation of America Hails Significant Provisions for Dementia Community in Health Reform Law 4Health News:Decreasing health-care costs is focus of new informatics book by NJIT professor 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: